August 6, 2020
Treatment Action Group Regrets NYC Health Commissioner Oxiris Barbot’s Resignation
Statement / Press
Treatment Action Group, the New York City-based research, policy, and advocacy organization, deplores the August 4, 2020 departure of New York’s Department of Health Commissioner, Dr. Oxiris Barbot, MD.

August 3, 2020
Letter to Sanofi CEO Calling for Patent Withdrawals on Critical TB Drugs
Letter / Comment
TAG and our French partners OTMeds (Observatoire de la transparence dans les politiques du médicaments) sent a letter to Sanofi CEO Paul Hudson calling on the company to reverse its efforts to patent two obvious combinations of two critical drugs to prevent tuberculosis: rifapentine and isoniazid.

July 28, 2020
An Activist’s Guide to Treatment for Drug-Resistant Tuberculosis
Publication
The 2020 updates to the World Health Organization (WHO) guidelines shifted the global standard of care for drug-resistant TB in a number of important ways. Our publication, An Activist’s Guide to Treatment for Drug-Resistant Tuberculosis, details these shifts and other important information about the new global standard of care for…

July 28, 2020
An Activist’s Guide to Tuberculosis Diagnostic Tools
Publication
Our publication, An Activist’s Guide to Tuberculosis Diagnostic Tools, details the latest WHO recommendations, the array of available TB diagnostic tools, and how these tools should be optimally used in country programs, including to support TB screening and diagnosis among special populations such as children, people with extrapulmonary TB, and…

July 27, 2020
Community Letter on COVID-19 Data Transparency and CDC Reform
Letter / Comment
TAG signed this letter from HIV organizations strongly recommending that the Administration reverse its decision to bypass the CDC in the collection & analysis of COVID-19 patient data, and that CDC internally address a culture of institutional racism described in a letter from 1,200 CDC employees to Dir. Robert Redfield.